Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (20491)	5/11/1998 6:43:00 PM
From: Andrew H	Read Replies (3) \| Respond to of 32384

Bob, must admit I am not impressed with the acquisition of the company or the drug. LGND must think it will help them, but I am not convinced. My guess is that the market will not reward them for this. However, it should reward them for the NDA on Panretin.

To: Machaon who wrote (20491)	5/11/1998 6:52:00 PM
From: RXGOLF	Read Replies (1) \| Respond to of 32384

Off Topic, then on topic: I had TXB in 2 lots, one for myself and one my wife. I bought them several days ago at 7 15/16. I told my wife I was selling at 9 on Friday. She followed my lead without my knowing-Thank the stock GODS! I don't like the acquisition, but maybe the street will. I will have to trust(and do)that our CEO knows how to make Ligand profitable more quickly. I do like the volume, and we won't be disappointed. Good Luck, GREG PS:I now pray to the stock GODS for my DAVX #:- >.